The Diagnostic Evidence Co-operative Newcastle is funded by the National Institute for Health Research and is a partnership between Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University

There has typically been a perception that companies making in vitro diagnostics (IVDs) have been dissuaded from investing in the UK due to a fragmented and heavily regulated evaluation system that results in many new tests never reaching the NHS and benefiting patients.

The NIHR Diagnostic Evidence Co-operatives (DECs) are specifically designed to dismantle these hurdles by providing one continuous support service. This will take diagnostic tests through rigorous clinical and economic evaluation.  This objective, high-quality evidence can then be used by companies to demonstrate the value of their product to the NHS. 

At the core of the DEC Newcastle's service is medical research excellence, and the availability of large, well-characterised groups of patients, and tissue and blood samples held in our biobanks . Our aim is to provide a smooth, fast, responsive system that is attractive to IVD companies of all sizes, which leads to a far greater proportion of high quality, cost-effective diagnostic tests entering the NHS for patient benefit.

The NIHR DEC Newcastle is able to work with companies across a broad range of clinical themes including,
but not limited to:
  • Infectious disease
  • Molecular genetics
  • Liver disease
  • Stroke and cardiovascular
  • Respiratory
  • Musculoskeletal
  • Cancer
The NIHR DEC Newcastle works closely with the NIHR Newcastle Biomedical Research Centre (BRC) by researching diagnostic tests for long-term conditions associated with ageing.